UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2017
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE TRANSITION PERIOD FROM TO
Commission file number 001-13795
AMERICAN VANGUARD CORPORATION
Delaware |
95-2588080 |
(State or other jurisdiction of Incorporation or organization) |
(I.R.S. Employer Identification Number) |
|
|
4695 MacArthur Court, Newport Beach, California |
92660 |
(Address of principal executive offices) |
(Zip Code) |
(949) 260-1200
(Registrant’s telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer |
☐ |
|
Accelerated Filer |
☒ |
Non-Accelerated Filer |
☐ |
(Do not check if a small reporting company) |
Smaller reporting company |
☐ |
Emerging growth company |
☐ |
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Common Stock, $.10 Par Value—29,783,825 shares as of July 25, 2017.
INDEX
2
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
|
|
For the Three Months Ended June 30, |
|
|
For the Six Months Ended June 30, |
|
||||||||||
|
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
Net sales |
|
$ |
77,905 |
|
|
$ |
72,724 |
|
|
$ |
148,578 |
|
|
$ |
142,198 |
|
Cost of sales |
|
|
43,570 |
|
|
|
41,329 |
|
|
|
84,159 |
|
|
|
83,300 |
|
Gross profit |
|
|
34,335 |
|
|
|
31,395 |
|
|
|
64,419 |
|
|
|
58,898 |
|
Operating expenses |
|
|
27,654 |
|
|
|
26,270 |
|
|
|
52,605 |
|
|
|
49,143 |
|
Operating income |
|
|
6,681 |
|
|
|
5,125 |
|
|
|
11,814 |
|
|
|
9,755 |
|
Interest expense, net |
|
|
400 |
|
|
|
462 |
|
|
|
698 |
|
|
|
1,003 |
|
Income before provision for income taxes and loss on equity method investment |
|
|
6,281 |
|
|
|
4,663 |
|
|
|
11,116 |
|
|
|
8,752 |
|
Income tax expense |
|
|
1,681 |
|
|
|
1,234 |
|
|
|
3,061 |
|
|
|
2,294 |
|
Income before loss on equity method investment |
|
|
4,600 |
|
|
|
3,429 |
|
|
|
8,055 |
|
|
|
6,458 |
|
Loss from equity method investment |
|
|
69 |
|
|
|
47 |
|
|
|
111 |
|
|
|
129 |
|
Net income |
|
|
4,531 |
|
|
|
3,382 |
|
|
|
7,944 |
|
|
|
6,329 |
|
Income attributable to non-controlling interest |
|
|
(227 |
) |
|
|
(136 |
) |
|
|
(188 |
) |
|
|
(289 |
) |
Net income attributable to American Vanguard |
|
$ |
4,304 |
|
|
$ |
3,246 |
|
|
$ |
7,756 |
|
|
$ |
6,040 |
|
Earnings per common share—basic |
|
$ |
.15 |
|
|
$ |
.11 |
|
|
$ |
.27 |
|
|
$ |
.21 |
|
Earnings per common share—assuming dilution |
|
$ |
.15 |
|
|
$ |
.11 |
|
|
$ |
.26 |
|
|
$ |
.21 |
|
Weighted average shares outstanding—basic |
|
|
29,050 |
|
|
|
28,893 |
|
|
|
28,999 |
|
|
|
28,851 |
|
Weighted average shares outstanding—assuming dilution |
|
|
29,605 |
|
|
|
29,377 |
|
|
|
29,561 |
|
|
|
29,342 |
|
See notes to the condensed consolidated financial statements.
3
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
(Unaudited)
|
|
For the Three Months Ended June 30, |
|
|
For the Six Months Ended June 30, |
|
||||||||||
|
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
Net income |
|
$ |
4,531 |
|
|
$ |
3,382 |
|
|
$ |
7,944 |
|
|
$ |
6,329 |
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
|
|
280 |
|
|
|
(537 |
) |
|
|
1,037 |
|
|
|
(452 |
) |
Comprehensive income |
|
|
4,811 |
|
|
|
2,845 |
|
|
|
8,981 |
|
|
|
5,877 |
|
Income attributable to non-controlling interest |
|
|
(227 |
) |
|
|
(136 |
) |
|
|
(188 |
) |
|
|
(289 |
) |
Comprehensive income attributable to American Vanguard |
|
$ |
4,584 |
|
|
$ |
2,709 |
|
|
$ |
8,793 |
|
|
$ |
5,588 |
|
See notes to the condensed consolidated financial statements.
4
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
ASSETS
|
|
June 30, 2017 |
|
|
Dec. 31, 2016 |
|
||
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
7,597 |
|
|
$ |
7,869 |
|
Receivables: |
|
|
|
|
|
|
|
|
Trade, net of allowance for doubtful accounts of $41 and $42, respectively |
|
|
63,291 |
|
|
|
83,777 |
|
Other |
|
|
3,912 |
|
|
|
3,429 |
|
Total receivables, net |
|
|
67,203 |
|
|
|
87,206 |
|
Inventories |
|
|
126,865 |
|
|
|
120,576 |
|
Prepaid expenses |
|
|
12,609 |
|
|
|
11,424 |
|
Total current assets |
|
|
214,274 |
|
|
|
227,075 |
|
Property, plant and equipment, net |
|
|
50,383 |
|
|
|
50,295 |
|
Intangible assets, net of applicable amortization |
|
|
130,806 |
|
|
|
121,433 |
|
Other assets |
|
|
30,135 |
|
|
|
31,153 |
|
|
|
$ |
425,598 |
|
|
$ |
429,956 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|||||||
Current liabilities: |
|
|
|
|
|
|
|
|
Current installments of other liabilities |
|
$ |
66 |
|
|
$ |
26 |
|
Accounts payable |
|
|
25,560 |
|
|
|
24,358 |
|
Deferred revenue |
|
|
1,722 |
|
|
|
3,848 |
|
Accrued program costs |
|
|
61,749 |
|
|
|
42,930 |
|
Accrued expenses and other payables |
|
|
7,988 |
|
|
|
12,072 |
|
Income taxes payable |
|
|
1,063 |
|
|
|
13,840 |
|
Total current liabilities |
|
|
98,148 |
|
|
|
97,074 |
|
Long-term debt, net of deferred loan fees |
|
|
26,348 |
|
|
|
40,951 |
|
Other liabilities, excluding current installments |
|
|
2,815 |
|
|
|
2,868 |
|
Deferred income tax liabilities |
|
|
6,713 |
|
|
|
6,706 |
|
Total liabilities |
|
|
134,024 |
|
|
|
147,599 |
|
Commitments and contingent liabilities |
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued |
|
|
— |
|
|
|
— |
|
Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 32,212,124 shares at June 30, 2017 and 31,819,695 shares at December 31, 2016 |
|
|
3,222 |
|
|
|
3,183 |
|
Additional paid-in capital |
|
|
72,768 |
|
|
|
71,699 |
|
Accumulated other comprehensive loss |
|
|
(3,814 |
) |
|
|
(4,851 |
) |
Retained earnings |
|
|
227,312 |
|
|
|
220,428 |
|
|
|
|
299,488 |
|
|
|
290,459 |
|
Less treasury stock at cost, 2,450,634 shares at June 30, 2017 and December 31, 2016 |
|
|
(8,269 |
) |
|
|
(8,269 |
) |
American Vanguard Corporation stockholders’ equity |
|
|
291,219 |
|
|
|
282,190 |
|
Non-controlling interest |
|
|
355 |
|
|
|
167 |
|
Total stockholders’ equity |
|
|
291,574 |
|
|
|
282,357 |
|
|
|
$ |
425,598 |
|
|
$ |
429,956 |
|
See notes to the condensed consolidated financial statements.
5
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
For The Three and Six Months Ended June 30, 2017
(In thousands, except share data)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
|
Additional |
|
|
Accumulated Other |
|
|
|
|
|
|
Treasury Stock |
|
|
|
|
|
|
Non- |
|
|
|
|
|
|||||||||||||
|
|
Shares |
|
|
Amount |
|
|
Paid-in Capital |
|
|
Comprehensive Loss |
|
|
Retained Earnings |
|
|
Shares |
|
|
Amount |
|
|
AVD Total |
|
|
Controlling Interest |
|
|
Total |
|
||||||||||
Balance, December 31, 2016 |
|
|
31,819,695 |
|
|
$ |
3,183 |
|
|
$ |
71,699 |
|
|
$ |
(4,851 |
) |
|
$ |
220,428 |
|
|
|
2,450,634 |
|
|
$ |
(8,269 |
) |
|
$ |
282,190 |
|
|
$ |
167 |
|
|
$ |
282,357 |
|
Stocks issued under ESPP |
|
|
16,349 |
|
|
|
2 |
|
|
|
248 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
250 |
|
|
|
— |
|
|
|
250 |
|
Cash dividends on common stock ($0.015 per share) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(435 |
) |
|
|
— |
|
|
|
— |
|
|
|
(435 |
) |
|
|
— |
|
|
|
(435 |
) |
Foreign currency translation adjustment, net |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
757 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
757 |
|
|
|
— |
|
|
|
757 |
|
Stock based compensation |
|
|
— |
|
|
|
— |
|
|
|
1,080 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,080 |
|
|
|
— |
|
|
|
1,080 |
|
Stock options exercised; grants and vesting of restricted stock units |
|
|
377,916 |
|
|
|
37 |
|
|
|
16 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
53 |
|
|
|
— |
|
|
|
53 |
|
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,452 |
|
|
|
— |
|
|
|
— |
|
|
|
3,452 |
|
|
|
(39 |
) |
|
|
3,413 |
|
Balance, March 31, 2017 |
|
|
32,213,960 |
|
|
|
3,222 |
|
|
|
73,043 |
|
|
|
(4,094 |
) |
|
|
223,445 |
|
|
|
2,450,634 |
|
|
|
(8,269 |
) |
|
|
287,347 |
|
|
|
128 |
|
|
|
287,475 |
|
Cash dividends on common stock ($0.015 per share) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(437 |
) |
|
|
— |
|
|
|
— |
|
|
|
(437 |
) |
|
|
— |
|
|
|
(437 |
) |
Foreign currency translation adjustment, net |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
280 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
280 |
|
|
|
— |
|
|
|
280 |
|
Stock based compensation |
|
|
— |
|
|
|
— |
|
|
|
1,242 |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
1,242 |
|
|
|
— |
|
|
|
1,242 |
|
Stock options exercised; grants and vesting of restricted stock units |
|
|
(1,836 |
) |
|
|
— |
|
|
|
(1,517 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,517 |
) |
|
|
— |
|
|
|
(1,517 |
) |
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4,304 |
|
|
|
— |
|
|
|
— |
|
|
|
4,304 |
|
|
|
227 |
|
|
|
4,531 |
|
Balance, June 30, 2017 |
|
|
32,212,124 |
|
|
$ |
3,222 |
|
|
$ |
72,768 |
|
|
$ |
(3,814 |
) |
|
$ |
227,312 |
|
|
|
2,450,634 |
|
|
$ |
(8,269 |
) |
|
$ |
291,219 |
|
|
$ |
355 |
|
|
$ |
291,574 |
|
See notes to the condensed consolidated financial statements.
6
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
|
|
For the Six Months Ended June 30, |
|
|||||
|
|
2017 |
|
|
2016 |
|
||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
7,944 |
|
|
$ |
6,329 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization of fixed and intangible assets |
|
|
8,094 |
|
|
|
8,359 |
|
Amortization of other long term assets |
|
|
2,777 |
|
|
|
2,358 |
|
Amortization of discounted liabilities |
|
|
13 |
|
|
|
19 |
|
Stock-based compensation |
|
|
2,322 |
|
|
|
1,068 |
|
Excess tax benefit from exercise of stock options |
|
|
— |
|
|
|
(47 |
) |
Increase in deferred income taxes |
|
|
7 |
|
|
|
— |
|
Loss from equity method investment |
|
|
111 |
|
|
|
129 |
|
Changes in assets and liabilities associated with operations: |
|
|
|
|
|
|
|
|
Decrease (increase) in net receivables |
|
|
20,749 |
|
|
|
(4,156 |
) |
Increase in inventories |
|
|
(5,506 |
) |
|
|
(14,625 |
) |
Increase in prepaid expenses and other assets |
|
|
(2,658 |
) |
|
|
(2,661 |
) |
(Increase) decrease in income tax receivable/payable, net |
|
|
(12,752 |
) |
|
|
1,244 |
|
Increase in accounts payable |
|
|
579 |
|
|
|
9,837 |
|
Decrease in deferred revenue |
|
|
(2,126 |
) |
|
|
(1,932 |
) |
Increase in program payables |
|
|
18,819 |
|
|
|
17,956 |
|
(Decrease) increase in other payables and accrued expenses |
|
|
(4,256 |
) |
|
|
1,612 |
|
Net cash provided by operating activities |
|
|
34,117 |
|
|
|
25,490 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(4,155 |
) |
|
|
(1,729 |
) |
Investment |
|
|
(950 |
) |
|
|
(3,283 |
) |
Acquisition of product lines and other intangible assets |
|
|
(13,400 |
) |
|
|
(224 |
) |
Net cash used in investing activities |
|
|
(18,505 |
) |
|
|
(5,236 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Payments under line of credit agreement |
|
|
(59,025 |
) |
|
|
(45,850 |
) |
Borrowings under line of credit agreement |
|
|
45,000 |
|
|
|
27,000 |
|
Payments on other long-term liabilities |
|
|
(26 |
) |
|
|
(457 |
) |
Tax benefit from exercise of stock options |
|
|
— |
|
|
|
47 |
|
Net payments from the issuance of common stock (sale of stock under ESPP, exercise of stock options, and shares purchased for tax withholding) |
|
|
(1,214 |
) |
|
|
(195 |
) |
Payment of cash dividends |
|
|
(724 |
) |
|
|
— |
|
Net cash used in by financing activities |
|
|
(15,989 |
) |
|
|
(19,455 |
) |
Net (decrease) increase in cash and cash equivalents |
|
|
(377 |
) |
|
|
799 |
|
Effect of exchange rate changes on cash and cash equivalents |
|
|
105 |
|
|
|
(524 |
) |
Cash and cash equivalents at beginning of period |
|
|
7,869 |
|
|
|
5,524 |
|
Cash and cash equivalents at end of period |
|
$ |
7,597 |
|
|
$ |
5,799 |
|
See notes to the condensed consolidated financial statements.
7
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(In thousands, except share data)
(Unaudited)
1. The accompanying unaudited condensed consolidated financial statements of American Vanguard Corporation and Subsidiaries (“AVD”) have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by US GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation, have been included. Operating results for the six months ended June 30, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. For further information, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.
2. Property, plant and equipment at June 30, 2017 and December 31, 2016 consists of the following:
|
|
June 30, 2017 |
|
|
December 31, 2016 |
|
||
Land |
|
$ |
2,458 |
|
|
$ |
2,458 |
|
Buildings and improvements |
|
|
16,567 |
|
|
|
15,515 |
|
Machinery and equipment |
|
|
107,278 |
|
|
|
102,146 |
|
Office furniture, fixtures and equipment |
|
|
4,952 |
|
|
|
5,016 |
|
Automotive equipment |
|
|
398 |
|
|
|
387 |
|
Construction in progress |
|
|
1,324 |
|
|
|
8,047 |
|
Total gross value |
|
|
132,977 |
|
|
|
133,569 |
|
Less accumulated depreciation |
|
|
(82,594 |
) |
|
|
(83,274 |
) |
Total net value |
|
$ |
50,383 |
|
|
$ |
50,295 |
|
The Company recognized depreciation expense related to property, plant and equipment of $2,129 and $2,059 for the three months ended June 30, 2017 and 2016, respectively. During the three months ended June 30, 2017 and 2016, the Company eliminated from assets and accumulated depreciation $3,584 and $2, respectively, of fully depreciated assets.
The Company recognized depreciation expense related to property, plant and equipment of $4,079 and $4,313 for the six months ended June 30, 2017 and 2016, respectively. During the six months ended June 30, 2017 and 2016, the Company eliminated from assets and accumulated depreciation $4,759 and $125, respectively, of fully depreciated assets.
Substantially all of the Company’s assets are pledged as collateral with its banks.
3. Inventories are stated at the lower of cost or market. Cost is determined using the first-in, first-out method. The components of inventories consist of the following:
|
|
June 30, 2017 |
|
|
December 31, 2016 |
|
||
Finished products |
|
$ |
107,319 |
|
|
$ |
103,832 |
|
Raw materials |
|
|
19,546 |
|
|
|
16,744 |
|
|
|
$ |
126,865 |
|
|
$ |
120,576 |
|
As of June 30, 2017, we believe our inventories are valued at lower of cost or market.
In July 2015, Financial Accounting Standards Board (“FASB”) issued Accounting Standards Codification (“ASU”) 2015-11, Inventory (Topic 330). Topic 330 currently requires an entity to measure inventory at the lower of cost or market, where market could be replacement cost, net realizable value, or net realizable value less an approximately normal profit margin. This ASU limits the scope to inventory that is measured using first-in, first-out (FIFO) or average cost and requires inventory be measured at the lower of costs or net realizable value. The new standard is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The Company adopted this new standard effective January 1, 2017. There was no impact on this adoption.
8
4. Based on similar economic and operational characteristics, the Company’s business is aggregated into one reportable segment. Selective enterprise information is as follows:
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
||||||||||
|
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
Net sales: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insecticides |
|
$ |
39,442 |
|
|
$ |
30,912 |
|
|
$ |
77,384 |
|
|
$ |
64,018 |
|
Herbicides/soil fumigants/fungicides |
|
|
16,045 |
|
|
|
21,093 |
|
|
|
36,066 |
|
|
|
45,767 |
|
Other, including plant growth regulators |
|
|
10,096 |
|
|
|
6,331 |
|
|
|
13,488 |
|
|
|
9,820 |
|
Net sales: |
|
|
65,583 |
|
|
|
58,336 |
|
|
|
126,938 |
|
|
|
119,605 |
|
Non-crop |
|
|
12,322 |
|
|
|
14,388 |
|
|
|
21,640 |
|
|
|
22,593 |
|
Total net sales: |
|
$ |
77,905 |
|
|
$ |
72,724 |
|
|
$ |
148,578 |
|
|
$ |
142,198 |
|
Net sales: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
US |
|
$ |
55,760 |
|
|
$ |
51,773 |
|
|
$ |
108,004 |
|
|
$ |
101,628 |
|
International |
|
|
22,145 |
|
|
|
20,951 |
|
|
|
40,574 |
|
|
|
40,570 |
|
Total net sales: |
|
$ |
77,905 |
|
|
$ |
72,724 |
|
|
$ |
148,578 |
|
|
$ |
142,198 |
|
5. Accrued Program Costs—In accordance with FASB ASC 605, the Company classifies amounts expected to be paid to its customers as a reduction of sales revenues. The Company describes these payments as “Programs.” Programs are a critical part of doing business in the agricultural chemicals business market place. For accounting purposes, programs are recorded as a reduction in gross sales and include market pricing adjustments, volume take up or other key performance indicator driven payments made to distributors, retailers or growers, at the end of a growing season. Each quarter management compares individual sale transactions with published programs to determine what, if any, program liability has been incurred. Once this initial calculation is made for the specific quarter, sales and marketing management, along with executive and financial management, review the accumulated program balance and make assessments of whether or not customers are tracking in a manner that indicates that they will meet the requirements set out in the terms and conditions attached to each Program. If management believes that customers are falling short of or exceeding their annual goals, then periodic adjustments will be made to the accumulated accrual to properly reflect the Company’s best estimate of the liability at the balance sheet date. The majority of adjustments are made at the end of the crop season, at which time customer performance can be more fully assessed. Programs are paid out predominantly on an annual basis, usually in the final quarter of the financial year or the first quarter of the following year. No significant changes in previous estimates were made during the three and six months ended June 30, 2017 and 2016, respectively.
6. The Company has declared and paid the following cash dividends in the periods covered by this Form 10-Q:
Declaration Date |
|
Record Date |
|
Distribution Date |
|
Dividend Per Share |
|
|
Total Paid |
|
||
June 8, 2017 |
|
June 30, 2017 |
|
July 14, 2017 |
|
$ |
0.015 |
|
|
$ |
437 |
|
March 7, 2017 |
|
March 31, 2017 |
|
April 14, 2017 |
|
$ |
0.015 |
|
|
$ |
435 |
|
December 18, 2016 |
|
December 23, 2016 |
|
January 6, 2017 |
|
$ |
0.010 |
|
|
$ |
289 |
|
7. ASC 260 Earnings Per Share (“EPS”) requires dual presentation of basic EPS and diluted EPS on the face of the condensed consolidated statements of operations. Basic EPS is computed as net income divided by the weighted average number of shares of common stock outstanding during the period. Diluted EPS reflects potential dilution that could occur if securities or other contracts, which, for the Company, consists of options to purchase shares of the Company’s common stock, are exercised.
The components of basic and diluted earnings per share were as follows:
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
||||||||||
|
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to AVD |
|
$ |
4,304 |
|
|
$ |
3,246 |
|
|
$ |
7,756 |
|
|
$ |
6,040 |
|
Denominator: (in thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding-basic |
|
|
29,050 |
|
|
|
28,893 |
|
|
|
28,999 |
|
|
|
28,851 |
|
Dilutive effect of stock options and grants |
|
|
555 |
|
|
|
484 |
|
|
|
562 |
|
|
|
491 |
|
|
|
|
29,605 |
|
|
|
29,377 |
|
|
|
29,561 |
|
|
|
29,342 |
|
9
For the three and six months ended June 30, 2017 and 2016, no stock options were excluded from the computation of diluted earnings per share.
8. The Company has a revolving line of credit that is shown as long-term debt in the condensed consolidated balance sheets at June 30, 2017 and December 31, 2016. The Company has no short term debt as of June 30, 2017 and December 31, 2016. These are summarized in the following table:
Long-term indebtedness ($000's) |
|
June 30, 2 |